サマリー

多血小板血漿（PRP）は、患者自身の血液を用いて、血液よりも血小板濃度の高い製品を得る生物学的療法である。再生医療に適した成長因子の制御されたドラッグデリバリーシステムとして、一過性のフィブリン足場を提供します。

市場分析と洞察。血小板豊富プラズマ療法の世界市場
血小板豊富プラズマ療法の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX％のCAGRで、2027年にXX百万米ドルに達すると予測されています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の血小板増量プラズマ療法市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には、収益面での世界の血小板増量プラズマ療法市場の全体的なサイズも含まれています。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の血小板増量プラズマ療法市場で永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されている調査結果、データ、情報はすべて、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の血小板増量プラズマ療法市場を詳細に調査するために、独自の業界最高の調査・分析手法を採用しました。

世界の血小板豊富プラズマ療法の範囲と市場規模
血小板増量プラズマ療法市場は、企業別、地域（国）別、タイプ別、用途別に分類されています。世界の血小板豊富プラズマ療法市場のプレーヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間におけるタイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
純粋なPRP
白血球リッチなPRP
白血球リッチフィブリン(L-PRF)

用途別セグメント
整形外科
ダーマトロジー
心筋梗塞
歯科
神経損傷
その他

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
テルモ
Arthrex
ジマー・バイオメット
デピュー・シンセシス
エムサイト
レーゲンラボ
ISTOバイオロジクス
Cesca Therapeutics
ウェイガオ
REV-MED
Nuo Therapeutics

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Platelet-rich Plasma Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pure PRP
1.2.3 Leucocyte-rich PRP
1.2.4 Leukocyte-rich Fibrin (L-PRF)
1.3 Market by Application
1.3.1 Global Platelet-rich Plasma Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Orthopedic
1.3.3 Darmatology
1.3.4 Cardiac Muscle Injury
1.3.5 Dental
1.3.6 Nerve Injury
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Platelet-rich Plasma Therapy Market Perspective (2016-2027)
2.2 Platelet-rich Plasma Therapy Growth Trends by Regions
2.2.1 Platelet-rich Plasma Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Platelet-rich Plasma Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Platelet-rich Plasma Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Platelet-rich Plasma Therapy Industry Dynamic
2.3.1 Platelet-rich Plasma Therapy Market Trends
2.3.2 Platelet-rich Plasma Therapy Market Drivers
2.3.3 Platelet-rich Plasma Therapy Market Challenges
2.3.4 Platelet-rich Plasma Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Platelet-rich Plasma Therapy Players by Revenue
3.1.1 Global Top Platelet-rich Plasma Therapy Players by Revenue (2016-2021)
3.1.2 Global Platelet-rich Plasma Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Platelet-rich Plasma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Platelet-rich Plasma Therapy Revenue
3.4 Global Platelet-rich Plasma Therapy Market Concentration Ratio
3.4.1 Global Platelet-rich Plasma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Platelet-rich Plasma Therapy Revenue in 2020
3.5 Platelet-rich Plasma Therapy Key Players Head office and Area Served
3.6 Key Players Platelet-rich Plasma Therapy Product Solution and Service
3.7 Date of Enter into Platelet-rich Plasma Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Platelet-rich Plasma Therapy Breakdown Data by Type
4.1 Global Platelet-rich Plasma Therapy Historic Market Size by Type (2016-2021)
4.2 Global Platelet-rich Plasma Therapy Forecasted Market Size by Type (2022-2027)

5 Platelet-rich Plasma Therapy Breakdown Data by Application
5.1 Global Platelet-rich Plasma Therapy Historic Market Size by Application (2016-2021)
5.2 Global Platelet-rich Plasma Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Platelet-rich Plasma Therapy Market Size (2016-2027)
6.2 North America Platelet-rich Plasma Therapy Market Size by Type
6.2.1 North America Platelet-rich Plasma Therapy Market Size by Type (2016-2021)
6.2.2 North America Platelet-rich Plasma Therapy Market Size by Type (2022-2027)
6.2.3 North America Platelet-rich Plasma Therapy Market Size by Type (2016-2027)
6.3 North America Platelet-rich Plasma Therapy Market Size by Application
6.3.1 North America Platelet-rich Plasma Therapy Market Size by Application (2016-2021)
6.3.2 North America Platelet-rich Plasma Therapy Market Size by Application (2022-2027)
6.3.3 North America Platelet-rich Plasma Therapy Market Size by Application (2016-2027)
6.4 North America Platelet-rich Plasma Therapy Market Size by Country
6.4.1 North America Platelet-rich Plasma Therapy Market Size by Country (2016-2021)
6.4.2 North America Platelet-rich Plasma Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Platelet-rich Plasma Therapy Market Size (2016-2027)
7.2 Europe Platelet-rich Plasma Therapy Market Size by Type
7.2.1 Europe Platelet-rich Plasma Therapy Market Size by Type (2016-2021)
7.2.2 Europe Platelet-rich Plasma Therapy Market Size by Type (2022-2027)
7.2.3 Europe Platelet-rich Plasma Therapy Market Size by Type (2016-2027)
7.3 Europe Platelet-rich Plasma Therapy Market Size by Application
7.3.1 Europe Platelet-rich Plasma Therapy Market Size by Application (2016-2021)
7.3.2 Europe Platelet-rich Plasma Therapy Market Size by Application (2022-2027)
7.3.3 Europe Platelet-rich Plasma Therapy Market Size by Application (2016-2027)
7.4 Europe Platelet-rich Plasma Therapy Market Size by Country
7.4.1 Europe Platelet-rich Plasma Therapy Market Size by Country (2016-2021)
7.4.2 Europe Platelet-rich Plasma Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size (2016-2027)
8.2 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type
8.2.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application
8.3.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region
8.4.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Platelet-rich Plasma Therapy Market Size (2016-2027)
9.2 Latin America Platelet-rich Plasma Therapy Market Size by Type
9.2.1 Latin America Platelet-rich Plasma Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Platelet-rich Plasma Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Platelet-rich Plasma Therapy Market Size by Type (2016-2027)
9.3 Latin America Platelet-rich Plasma Therapy Market Size by Application
9.3.1 Latin America Platelet-rich Plasma Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Platelet-rich Plasma Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Platelet-rich Plasma Therapy Market Size by Application (2016-2027)
9.4 Latin America Platelet-rich Plasma Therapy Market Size by Country
9.4.1 Latin America Platelet-rich Plasma Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Platelet-rich Plasma Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size (2016-2027)
10.2 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type
10.2.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application
10.3.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country
10.4.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Terumo
11.1.1 Terumo Company Details
11.1.2 Terumo Business Overview
11.1.3 Terumo Platelet-rich Plasma Therapy Introduction
11.1.4 Terumo Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.1.5 Terumo Recent Development
11.2 Arthrex
11.2.1 Arthrex Company Details
11.2.2 Arthrex Business Overview
11.2.3 Arthrex Platelet-rich Plasma Therapy Introduction
11.2.4 Arthrex Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.2.5 Arthrex Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Platelet-rich Plasma Therapy Introduction
11.3.4 Zimmer Biomet Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.3.5 Zimmer Biomet Recent Development
11.4 DePuy Synthes
11.4.1 DePuy Synthes Company Details
11.4.2 DePuy Synthes Business Overview
11.4.3 DePuy Synthes Platelet-rich Plasma Therapy Introduction
11.4.4 DePuy Synthes Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.4.5 DePuy Synthes Recent Development
11.5 EmCyte
11.5.1 EmCyte Company Details
11.5.2 EmCyte Business Overview
11.5.3 EmCyte Platelet-rich Plasma Therapy Introduction
11.5.4 EmCyte Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.5.5 EmCyte Recent Development
11.6 Regen Lab
11.6.1 Regen Lab Company Details
11.6.2 Regen Lab Business Overview
11.6.3 Regen Lab Platelet-rich Plasma Therapy Introduction
11.6.4 Regen Lab Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.6.5 Regen Lab Recent Development
11.7 ISTO Biologics
11.7.1 ISTO Biologics Company Details
11.7.2 ISTO Biologics Business Overview
11.7.3 ISTO Biologics Platelet-rich Plasma Therapy Introduction
11.7.4 ISTO Biologics Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.7.5 ISTO Biologics Recent Development
11.8 Cesca Therapeutics
11.8.1 Cesca Therapeutics Company Details
11.8.2 Cesca Therapeutics Business Overview
11.8.3 Cesca Therapeutics Platelet-rich Plasma Therapy Introduction
11.8.4 Cesca Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.8.5 Cesca Therapeutics Recent Development
11.9 Weigao
11.9.1 Weigao Company Details
11.9.2 Weigao Business Overview
11.9.3 Weigao Platelet-rich Plasma Therapy Introduction
11.9.4 Weigao Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.9.5 Weigao Recent Development
11.10 REV-MED
11.10.1 REV-MED Company Details
11.10.2 REV-MED Business Overview
11.10.3 REV-MED Platelet-rich Plasma Therapy Introduction
11.10.4 REV-MED Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.10.5 REV-MED Recent Development
11.11 Nuo Therapeutics
11.11.1 Nuo Therapeutics Company Details
11.11.2 Nuo Therapeutics Business Overview
11.11.3 Nuo Therapeutics Platelet-rich Plasma Therapy Introduction
11.11.4 Nuo Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.11.5 Nuo Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details